Bendamustine's emerging role in the management of lymphoid malignancies.

  title={Bendamustine's emerging role in the management of lymphoid malignancies.},
  author={Mathias Johannes Rummel and Stephanie A. Gregory},
  journal={Seminars in hematology},
  volume={48 Suppl 1},
The potent alkylating agent bendamustine has demonstrated substantial efficacy in patients with non-Hodgkin lymphomas (NHLs), including chronic lymphocytic leukemia (CLL), follicular lymphoma, and mantle cell lymphoma. Due to incomplete cross-reactivity between bendamustine and other chemotherapeutic agents, bendamustine has been extensively tested in the… CONTINUE READING